Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to IMMUNOTHERAPY

The New England Journal of Medicine

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer

Obstetrics & Gynecology April 18th 2024

OBR Oncology

FDA Approval for TIL Therapy “Real Milestone” That Has Been “Long Time Coming”

Hematology/Oncology April 8th 2024

Cancer Therapy Advisor

Treatment Approaches for Advanced Hepatocellular Carcinoma From ASCO GI 2024

Oncology, Medical April 1st 2024

The New England Journal of Medicine

Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma

Oncology, Medical March 18th 2024

Clinical Advances in Hematology & Oncology

Epcoritamab, a Promising Therapy for Richter Syndrome?

Hematology/Oncology March 18th 2024

The New England Journal of Medicine

Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer

Oncology, Medical March 11th 2024

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form